Israeli law does not regulate the ownership of intellectual property created by machine learning, and this should be regulated in collaboration agreements. However, it is generally accepted that the company conducting the research will have the rights to the resulting products, including their intellectual property rights. It is important to note that in Israel if the invention is a method in the field of healthcare (like precision medicine), two problems arise: (1) a patent shall not be granted for a procedure for a therapeutic treatment on the human body (section 7 of the Patents Law); and (2) discovery, scientific theory, mathematical formula, game instructions, and thought processes shall be considered abstract ideas or processes of a technical nature.